Cytokines as Therapeutic Targets to Reduce Cardiovascular Risk in Chronic Inflammation

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|17|1|1-8

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.17, Iss.1, 2011-01, pp. : 1-8

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Neutrophil-Derived Cytokines: Potential Therapeutic Targets in Inflammation

By  

Current Drug Targets. Inflammation & Allergy, Vol. 4, Iss. 3, 2005-06 ,pp. : 273-279

Bentham Science Publishers

Access to resources Recommend Favorite

Inflammation, Endothelial Dysfunction and Arterial Stiffness as Therapeutic Targets in Cardiovascular Medicine

By  

Current Pharmaceutical Design, Vol. 22, Iss. 30, 2016-09 ,pp. : 4658-4668

Bentham Science Publishers

Access to resources Recommend Favorite

Adenosine Receptors As Promising Therapeutic Targets for Drug Development in Chronic Airway Inflammation

By  

Current Drug Targets, Vol. 7, Iss. 6, 2006-06 ,pp. : 699-706

Bentham Science Publishers

Access to resources Recommend Favorite

Mammalian Antimicrobial Peptides: Promising Therapeutic Targets Against Infection and Chronic Inflammation

By  

Current Topics in Medicinal Chemistry, Vol. 16, Iss. 1, 2016-01 ,pp. : 99-129

Bentham Science Publishers

Access to resources Recommend Favorite

Tachykinins as Therapeutic Targets in Inflammation

By  

Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents, Vol. 2, Iss. 1, 2003-03 ,pp. : 19-27

Bentham Science Publishers

Access to resources Recommend Favorite